Found: 10
Select item for more details and to access through your institution.
Utilization of Rosuvastatin and Endogenous Biomarkers in Evaluating the Impact of Ritlecitinib on BCRP, OATP1B1, and OAT3 Transporter Activity.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 11, p. 2639, doi. 10.1007/s11095-023-03564-3
- By:
- Publication type:
- Article
Evaluation of the Impact of Ritlecitinib on Organic Cation Transporters Using Sumatriptan and Biomarkers as Probes.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 7, p. 784, doi. 10.1002/jcph.2215
- By:
- Publication type:
- Article
Estimation of the Effect of OAT2-Mediated Active Uptake on Meloxicam Exposure in the Human Liver.
- Published in:
- AAPS Journal, 2020, v. 22, n. 2, p. 1, doi. 10.1208/s12248-019-0409-8
- By:
- Publication type:
- Article
Reliable Rate Measurements for Active and Passive Hepatic Uptake Using Plated Human Hepatocytes.
- Published in:
- AAPS Journal, 2017, v. 19, n. 3, p. 787, doi. 10.1208/s12248-017-0051-2
- By:
- Publication type:
- Article
Erratum to: Reliable Rate Measurements for Active and Passive Hepatic Uptake Using Plated Human Hepatocytes.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Evaluation of the Effect of Abrocitinib on Drug Transporters by Integrated Use of Probe Drugs and Endogenous Biomarkers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 665, doi. 10.1002/cpt.2594
- By:
- Publication type:
- Article
Drug‐Drug Interactions Involving Renal OCT2/MATE Transporters: Clinical Risk Assessment May Require Endogenous Biomarker‐Informed Approach.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 4, p. 855, doi. 10.1002/cpt.2089
- By:
- Publication type:
- Article
Identification of Glycochenodeoxycholate 3‐O‐Glucuronide and Glycodeoxycholate 3‐O‐Glucuronide as Highly Sensitive and Specific OATP1B1 Biomarkers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 3, p. 646, doi. 10.1002/cpt.2053
- By:
- Publication type:
- Article
Identification of Appropriate Endogenous Biomarker for Risk Assessment of Multidrug and Toxin Extrusion Protein‐Mediated Drug‐Drug Interactions in Healthy Volunteers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 507, doi. 10.1002/cpt.2022
- By:
- Publication type:
- Article
Effect of Hepatic Organic Anion‐Transporting Polypeptide 1B Inhibition and Chronic Kidney Disease on the Pharmacokinetics of a Liver‐Targeted Glucokinase Activator: A Model‐Based Evaluation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 4, p. 792, doi. 10.1002/cpt.1419
- By:
- Publication type:
- Article